Literature DB >> 12654967

Predictors of nursing home placement in Huntington disease.

V L Wheelock1, T Tempkin, K Marder, M Nance, R H Myers, H Zhao, E Kayson, C Orme, I Shoulson.   

Abstract

OBJECTIVE: To determine whether motor, behavioral, or psychiatric symptoms in Huntington disease (HD) predict skilled nursing facility (SNF) placement.
METHODS: Subjects were participants in the Huntington Study Group's Unified Huntington Disease Rating Scale Database (Rochester, NY) between January 1994 and September 1999. Specific motor, psychiatric, and behavioral variables in subjects residing at home and in SNF were analyzed using chi2 and Student's t-tests. For a subset of subjects for whom longitudinal data existed, a Cox proportional hazards model controlling for age, sex, and disease duration was used.
RESULTS: Among 4,809 subjects enrolled, 3,070 had clinically definite HD. Of these, 228 (7.4%) resided in SNF. The SNF residents' average age was 52 years, average disease duration was 8.6 years, and they were predominantly women (63%). The SNF residents had worse motor function (chorea, bradykinesia, gait abnormality, and imbalance, p < 0.0001); were more likely to have obsessions, compulsions, delusions, and auditory hallucinations; and had more aggressive, disruptive (p < 0.0001), and irritable behaviors (p = 0.0012). For 1,559 subjects, longitudinal data existed (average length of follow-up, 1.9 years), and 87 (5%) moved from home to SNF. In the Cox model, bradykinesia (HR 1.965, 95% CI 1.083 to 3.564), impaired gait (HR 3.004, 95% CI 1.353 to 6.668), and impaired tandem walking (HR 2.546, 95% CI 1.460 to 4.439) were predictive of SNF placement.
CONCLUSIONS: Institutionalized patients with HD are more motorically, psychiatrically, and behaviorally impaired than their counterparts living at home. However, motor variables alone predicted institutionalization. Treatment strategies that delay the progression of motor dysfunction in HD may postpone the need for institutionalization.

Entities:  

Mesh:

Year:  2003        PMID: 12654967     DOI: 10.1212/01.wnl.0000052992.58107.67

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  34 in total

1.  A randomized controlled trial of an activity specific exercise program for individuals with Alzheimer disease in long-term care settings.

Authors:  Kathryn E Roach; Ruth M Tappen; Neva Kirk-Sanchez; Christine L Williams; David Loewenstein
Journal:  J Geriatr Phys Ther       Date:  2011 Apr-Jun       Impact factor: 3.381

2.  Heart rate variability and falls in Huntington's disease.

Authors:  Daniel E Vigo; Marcelo Merello; Cinthia Terroba-Chambi; Veronica Bruno
Journal:  Clin Auton Res       Date:  2020-02-06       Impact factor: 4.435

3.  Functional brain changes underlying irritability in premanifest Huntington's disease.

Authors:  Jan Van den Stock; François-Laurent De Winter; Rawaha Ahmad; Stefan Sunaert; Koen Van Laere; Wim Vandenberghe; Mathieu Vandenbulcke
Journal:  Hum Brain Mapp       Date:  2015-04-08       Impact factor: 5.038

4.  Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease.

Authors:  Chi-Tso Chiu; Guangping Liu; Peter Leeds; De-Maw Chuang
Journal:  Neuropsychopharmacology       Date:  2011-07-27       Impact factor: 7.853

5.  Deficits in stepping response time are associated with impairments in balance and mobility in people with Huntington disease.

Authors:  Allon Goldberg; Stacey L Schepens; Shawna M E Feely; James Y Garbern; Lindsey J Miller; Carly E Siskind; Gerry E Conti
Journal:  J Neurol Sci       Date:  2010-11-15       Impact factor: 3.181

6.  Irritability in pre-clinical Huntington's disease.

Authors:  Stefan Klöppel; Cynthia M Stonnington; Predrag Petrovic; Dean Mobbs; Oliver Tüscher; David Craufurd; Sarah J Tabrizi; Richard S J Frackowiak
Journal:  Neuropsychologia       Date:  2009-10-28       Impact factor: 3.139

Review 7.  Determinants of functional disability in Huntington's disease: role of cognitive and motor dysfunction.

Authors:  Christopher A Ross; Alex Pantelyat; Jane Kogan; Jason Brandt
Journal:  Mov Disord       Date:  2014-09-15       Impact factor: 10.338

8.  The development of a new computer adaptive test to evaluate chorea in Huntington disease: HDQLIFE Chorea.

Authors:  N E Carlozzi; N R Downing; S G Schilling; J-S Lai; S M Goodnight; J A Miner; S A Frank
Journal:  Qual Life Res       Date:  2016-05-03       Impact factor: 4.147

9.  Survival of Huntington's disease patients in Serbia: longer survival in female patients.

Authors:  Tatjana Pekmezovic; Marina Svetel; Jelena Maric; Irena Dujmovic-Basuroski; Natasa Dragasevic; Milica Keckarevic; Stanka Romac; Vladimir S Kostic
Journal:  Eur J Epidemiol       Date:  2007-07-25       Impact factor: 8.082

Review 10.  Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder.

Authors:  Chi-Tso Chiu; Zhifei Wang; Joshua G Hunsberger; De-Maw Chuang
Journal:  Pharmacol Rev       Date:  2013-01-08       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.